Daratumumab Biosimilar - Anti-CD38 Antibody - BSA and Azide free (A318952)

Daratumumab Biosimilar - Anti-CD38 Antibody - BSA and Azide free

Recombinant human monoclonal antibody to CD38.

ELISA, Flow Cytometry

ELISA: 1:5,000-10,000, Flow Cytometry: 1:100

Human

Human

Monoclonal

IgG1

Unconjugated

Affinity chromatography.

Reconstitution dependent.

Reconstitute with distilled sterile water.

Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.

Acute lymphoblastic leukemia cells antigen CD38, ADP ribosyl cyclase, ADP ribosyl cyclase 1, ADP ribosyl cyclase/cyclic ADP-ribose hydrolase, ADP-ribosyl cyclase 1, ADPRC 1, ADPRC1, cADPr hydrolase 1, CD 38, CD38 antigen, CD38 antigen (p45), CD38 molecule, Cd38-rs1, CD38H, CD38_HUMAN, Cyclic ADP ribose hydrolase, Cyclic ADP ribose hydrolase 1, Cyclic ADP-ribose hydrolase 1, EC 3.2.2.5, Ecto nicotinamide adenine dinucleotide glycohydrolase, I-19, I19 (mouse), Lymphocyte differentiation antigen CD38, NAD(+) nucleosidase, NIM-R5 antigen, NIMR5 antigen (mouse), OTTHUMP00000158633, OTTHUMP00000217743, p45, T10